A novel biodegradable gel delivers Parkinson's medications via a single weekly shot, potentially replacing current regimens of multiple pills per day. | Drug Discovery And Development ...

Parkinson's Disease Therapeutics Market The Parkinson's therapeutics market will grow from USD 5.92 Bn in 2024 to USD 12.83 Bn by 2033 at 8 ...

Detailed price information for Sage Therapeutic Com (SAGE-Q) from The Globe and Mail including charting and trades.

AbbVie has launched its Produodopa for Parkinson’s in the EU, becoming the first and only 24-hour levodopa-based subcutaneous infusion therapy for the disease.

As described by the company, sepiapterin is a natural precursor of the enzymatic co-factor BH4 -- a critical co-factor for ...

Scientists from the University of South Australia (UniSA) have developed a new weekly injection that could greatly improve ...

AbbVie also sells another long-acting therapy for advanced Parkinson's called Duodopa (levodopa–carbidopa intestinal gel) which has been bringing in around $500 million a year in sales.

Researchers at Simon Fraser University (SFU) are using a new brain imaging method that could help doctors better understand ...

Parkinsonism can have many causes, among them cerebrovascular disease. Vascular parkinsonism can be caused by infarction or haemorrhage in the nigrostriatal pathway, resulting in hemiparkinsonism, or ...

Our proposed treatment algorithm for motor symptoms in Parkinson's disease. COMT = catechol-O-methyltransferase, LCIG = levodopa/carbidopa intestinal gel, LECIG = levodopa/entacapone/carbidopa ...

Deep brain stimulation (DBS) is a type of therapy that uses electrical stimulation to treat Parkinson’s disease, essential tremor, multiple sclerosis, and certain other neurological conditions.

If you have brittle nails, swollen hands or unusually pale fingertips it may be more than just a damper to your manicure. It ...